Condition
Systemic Lupus Erythematosus Arthritis
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (2)
Trial Status
Terminated2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT03355482Phase 2TerminatedPrimary
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT02429934Phase 1TerminatedPrimary
Abatacept for SLE Arthritis (IM101-330)
NCT04035265Not ApplicableUnknown
Application of MRI for Musculoskeletal Involvement in SLE
NCT03054259Phase 2UnknownPrimary
Rituximab Objective Outcome Measures Trial in SLE
Showing all 4 trials